NYSEARCA:YCBD - NYSE Arca - US12482W3097 - Common Stock - Currency: USD
NYSEARCA:YCBD (5/13/2025, 9:39:54 AM)
0.9263
-0.02 (-2.49%)
The current stock price of YCBD is 0.9263 USD. In the past month the price decreased by -45.75%. In the past year, price decreased by -83.4%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
LLY | ELI LILLY & CO | 53.89 | 702.99B | ||
JNJ | JOHNSON & JOHNSON | 14.92 | 360.89B | ||
NVO | NOVO-NORDISK A/S-SPONS ADR | 18.96 | 288.65B | ||
NVS | NOVARTIS AG-SPONSORED ADR | 12.94 | 212.40B | ||
AZN | ASTRAZENECA PLC-SPONS ADR | 18.13 | 209.12B | ||
MRK | MERCK & CO. INC. | 9.95 | 195.10B | ||
PFE | PFIZER INC | 7.02 | 127.88B | ||
SNY | SANOFI-ADR | 13.34 | 122.76B | ||
BMY | BRISTOL-MYERS SQUIBB CO | 6.36 | 95.00B | ||
GSK | GSK PLC-SPON ADR | 6.7 | 73.34B | ||
ZTS | ZOETIS INC | 26.7 | 71.70B | ||
HLN | HALEON PLC-ADR | 21.9 | 47.40B |
cbdMD, Inc. engages in the business of operating cannabidiol brands such as Paw cannabidiol and cbdMD botanicals. The company is headquartered in Charlotte, North Carolina and currently employs 42 full-time employees. The company went IPO on 2017-11-17. The firm has a comprehensive line of United States produced, THC-free CBD products, including NSF Certified for Sport products, as well as its new Full Spectrum products. The firm's flagship brands include cbdMD and Paw CBD, as well as its functional mushroom brand ATRx Labs. Its cbdMD brand includes high-grade, premium CBD products including CBD tinctures, CBD gummies, CBD topicals, CBD capsules, CBD sleep aids and CBD drink products including its Herbal Oasis Social Tonic and an array of Farm Act compliant Delta 9 products. Its Paw CBD brand of pet products includes veterinarian-formulated products including tinctures, chews, topicals products in varying strengths, and its ATRx brand of natural functional mushroom support. Its cbdMD, Paw CBD and ATRx products are distributed through its e-commerce websites, third party e-commerce sites, select distributors and marketing partners as well as a variety of brick-and-mortar retailers.
CBDMD INC
8845 Red Oak Blvd
Charlotte NORTH CAROLINA 28217 US
CEO: Martin A. Sumichrast
Employees: 42
Phone: 17044453060
The current stock price of YCBD is 0.9263 USD. The price decreased by -2.49% in the last trading session.
The exchange symbol of CBDMD INC is YCBD and it is listed on the NYSE Arca exchange.
YCBD stock is listed on the NYSE Arca exchange.
CBDMD INC (YCBD) has a market capitalization of 5.80M USD. This makes YCBD a Nano Cap stock.
CBDMD INC (YCBD) currently has 42 employees.
CBDMD INC (YCBD) has a resistance level at 1.57. Check the full technical report for a detailed analysis of YCBD support and resistance levels.
The Revenue of CBDMD INC (YCBD) is expected to grow by 9.38% in the next year. Check the estimates tab for more information on the YCBD EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
YCBD does not pay a dividend.
CBDMD INC (YCBD) will report earnings on 2025-05-14.
CBDMD INC (YCBD) does not have a PE ratio as the earnings reported over the last twelve months were negative (-10.24).
ChartMill assigns a fundamental rating of 2 / 10 to YCBD. YCBD may be in some trouble as it scores bad on both profitability and health.
Over the last trailing twelve months YCBD reported a non-GAAP Earnings per Share(EPS) of -10.24. The EPS increased by 90.68% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -57.98% | ||
ROE | -375.65% | ||
Debt/Equity | 0 |
ChartMill assigns a Buy % Consensus number of 83% to YCBD. The Buy consensus is the average rating of analysts ratings from 7 analysts.
For the next year, analysts expect an EPS growth of 71.11% and a revenue growth 9.38% for YCBD